^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LymphoCide Y-90 (epratuzumab Y-90)

    i
    Other names: IMMU-102, LCD-22-Y-90, hCD22, 90Y-DOTA-hLL2, 90Y-hLL2 IgG, anti-CD22 monoclonal antibody LL2-Y-90, hCD22-Y-90
    Associations
    News
    Trials
    Company:
    Gilead
    Drug class:
    Ionizing radiation emitter, CD22 inhibitor
    Related drugs:
    Associations
    News
    Trials